Accessibility Menu
 
NovoCure logo

NovoCure

(NASDAQ) NVCR

Current Price$11.83
Market Cap$1.34B
Since IPO (2015)-35%
5 Year-92%
1 Year-38%
1 Month+4%

NovoCure Financials at a Glance

Market Cap

$1.34B

Revenue (TTM)

$655.35M

Net Income (TTM)

$136.23M

EPS (TTM)

$-1.22

P/E Ratio

-9.66

Dividend

$0.00

Beta (Volatility)

1.43 (Average)

Price

$11.83

Volume

28,393

Open

$11.79

Previous Close

$11.83

Daily Range

$11.71 - $12.19

52-Week Range

$9.82 - $20.06

NVCR: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NovoCure

Industry

Healthcare Equipment and Supplies

Employees

1,605

CEO

Frank Leonard

Headquarters

Saint Helier, JE2 4UF, JE

NVCR Financials

Key Financial Metrics (TTM)

Gross Margin

75%

Operating Margin

-23%

Net Income Margin

-21%

Return on Equity

-39%

Return on Capital

-26%

Return on Assets

-17%

Earnings Yield

-10.35%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.34B

Shares Outstanding

113.79M

Volume

28.39K

Short Interest

0.00%

Avg. Volume

1.88M

Financials (TTM)

Gross Profit

$488.47M

Operating Income

$153.80M

EBITDA

$119.05M

Operating Cash Flow

$49.03M

Capital Expenditure

$26.65M

Free Cash Flow

$75.68M

Cash & ST Invst.

$457.52M

Total Debt

$290.00M

NovoCure Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$174.35M

+8.1%

Gross Profit

$132.19M

+3.4%

Gross Margin

75.82%

N/A

Market Cap

$1.34B

N/A

Market Cap/Employee

$903.16K

N/A

Employees

1,488

N/A

Net Income

$24.50M

+62.8%

EBITDA

$34.19M

-224.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$167.52M

-39.4%

Accounts Receivable

$115.35M

+13.0%

Inventory

$0.00

-100.0%

Long Term Debt

$278.34M

+137.3%

Short Term Debt

$11.66M

-97.9%

Return on Assets

-16.94%

N/A

Return on Invested Capital

-26.47%

N/A

Free Cash Flow

$22.90M

-84.8%

Operating Cash Flow

$18.00M

-421.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PLSEPulse Biosciences, Inc.
$20.93-5.29%
KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.
$19.59+2.57%
TDOCTeladoc Health, Inc.
$5.48+2.43%
AZTAAzenta, Inc.
$20.45+1.29%

Trending Stocks

Symbol / CompanyPricePrice Chg
UGROUrban-gro
$6.15+1.82%
TQQQProShares Trust - ProShares UltraPro Qqq
$44.57+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.95+0.07%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.58-0.03%

Questions About NVCR

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.